Most uninfected children born to diagnosed HIV-infected women are now exposed to antiretroviral therapy (ART) in utero and neonatally and concerns have been raised over the safety of this exposure. To explore parents' and health professionals' views on the long-term follow-up of uninfected children two related surveys were conducted in the UK. Questionnaires were completed by 140 parents/carers and 40 health professionals. Most of the respondents in both surveys (96% overall) acknowledged that it was important to follow up children to identify possible side effects from ART exposure. Almost all respondents (99%) found at least one of the strategies acceptable: follow-up through the clinic, by telephone, post or using data linkage. A third of parents and nearly half of health professionals strongly objected to at least one strategy, mostly postal and clinic contact respectively. The majority of parents (98%) thought they should be told if a potential health risk associated with ART exposure was identified; 73% of parents wanted any direct contact to be through them even when the child had grown up. Almost all respondents were supportive of the rationale for follow-up and, while expressing a preference for certain strategies, generally did not dismiss others. However, developing a single form of long-term follow-up which is both acceptable and feasible is challenging.
Introduction
HIV-infected pregnant women in resource-rich settings routinely take antiretroviral therapy (ART) to reduce the risk of mother-to-child transmission (MTCT), and MTCT rates of less than 2% can now be achieved (European Collaborative Study, 2005 , Cooper et al., 2002 . Women may also take ART during pregnancy for their own health (Hawkins et al., 2005) . While the benefits of ART in preventing paediatric HIV infections are clear, concerns have been raised over the safety of ART exposure for uninfected children (Mofenson & Munderi, 2002; Thorne & Newell, 2005) . Cases of mitochondrial dysfunction have been reported in exposed children (Blanche et al., 1999 , Barret et al., 2003 , and animal studies have suggested a risk of carcinogenesis with zidovudine exposure (Olivero et al., 1997) . However ART exposure has not been reported to be associated with cancer in early childhood (Culnane et al., 1999; Brogly et al., 2006) .
As cancer and other adverse outcomes potentially associated with ART exposure may not develop for many years, it is important to put in place long-term follow-up mechanisms which are ethical, practical and acceptable to HIV-affected families and those providing their healthcare.
In the UK routine surveillance of obstetric and paediatric HIV is conducted through the National Study of HIV in Pregnancy and Childhood (NSHPC) (Townsend et al., 2006) . Between 2002 and 2005 a consented, clinic-based follow-up study of uninfected children reported to the NSHPC was carried out to examine the logistics and feasibility of enrolling children in long-term follow-up, and to explore health outcomes in relation to type and timing of ART exposure (the CHART study). It became clear that enrolment and subsequent retention of families in this study was challenging, and in 2004/5 we therefore conducted two related questionnaire surveys to explore the views of parents and health professionals about this and other types of follow-up.
Methods

Parent survey
The parent survey was conducted in 12 paediatric HIV clinics and two genitourinary clinics. Clinics were selected to provide a geographical spread (one each in Cardiff, Glasgow, Leeds, Northampton, Slough and Southampton, and eight in London). Parents and other primary carers of ART-exposed uninfected children were approached to take part in the survey, which was conducted between October 2004 and June 2005. The study researcher attended six clinics on a total of 33 occasions, and invited potential respondents to take part; clinic staff approached potential respondents in the other eight clinics.
The questionnaire was developed in collaboration with clinicians and researchers, and piloted with parents from an HIV support group. Respondents completed the questionnaire anonymously and provided limited personal information about their family and their contact with health services. Respondents' views were sought on four potential longterm follow-up strategies, chosen to provide a range of intensity of contact from clinic-based follow-up to monitoring through data linkage (Table I) . Questions were mostly closed-ended, but more extensive comments were invited at the end of the questionnaire. The study was reviewed and approved by the London Multi-centre Research Ethics Committee (ref: 04/MRE02/48).
Health professional survey
A questionnaire and covering letter were sent to the NSHPC paediatric respondent (usually a paediatrician or paediatric specialist nurse) in 46 hospitals throughout the UK. Hospitals were included if at least 10 uninfected children born between January 2001 and April 2004 had been reported to the NSHPC and/or at least two children had been enrolled in the CHART study (Hankin et al., 2004) . Data collection was carried out between June and August 2005. The four follow-up strategies described in the parent questionnaire were outlined (Table I) , and respondents' views on their acceptability were sought.
Data analysis
A Microsoft Access 2002 database was used for data entry. Data analysis was conducted using SAS statistical software (version 9.1, SAS Institute, Cary, North Carolina, USA). Univariable comparisons of categorical variables were tested with x 2 tests.
Results
Parent survey
The study researcher approached 89 parents/carers in six clinics; 76 agreed to take part, a response rate of 85%. A further 64 parents were recruited by health professionals in the other eight clinics, giving a total of 140 respondents. For the results presented below, the denominator in parentheses relates to the number of respondents who answered the relevant question.
The majority of respondents (91%, 127/139) were mothers, 11 were fathers, and one was an aunt with parental responsibility. Of the mothers who reported their own country of birth, 9% (11/123) were born in the UK and 85% (105/123) in sub-Saharan Africa; four of the 11 fathers were born in the UK and the rest in sub-Saharan Africa. Most respondents (97%, 134/138) expected their children to continue living in the UK. Just over half of the respondents (53%, 74/140) cared for one child, 39 (28%) cared for two, 18 (13%) for three, and nine (6%) for four or more children. The median age of Table I . The four follow-up options presented in the parent questionnaire.
OPTION A (CLINIC CONTACT)
. You and/or your child would be asked to come to the family or paediatric clinic once a year. . Clinic staff would ask you general questions about your child's health. . The answers would be put on a form and sent to us. Neither your name nor your child's name would be on the form. . You would need to inform the clinic of any change in your contact details.
OPTION B (TELEPHONE CONTACT)
. Clinic staff would telephone you once a year and would ask you general questions about your child's health. . The answers would be put on a form and sent to us. Neither your name nor your child's name would be on the form. . You would not need to attend the clinic to take part, but you would need to inform the clinic of any change in your telephone number.
OPTION C (POSTAL CONTACT)
. The clinic staff would give us your contact details when your child was discharged. We would keep these in strict confidence. . We would send you a short form about your child's health once a year, for you to complete and send back to us. . There would be no reference to HIV on anything you were sent. . You would need to inform us of any change in your address.
OPTION D (NO DIRECT CONTACT)
. We would not need to have any regular direct contact with you or your child and we would not know your or your child's name or address. . Every child in the UK is given an NHS number at birth.
The clinic would give us your child's NHS number which we could relate to routinely available health information. . You would not have to keep in contact with the clinic after your child was discharged.
Note : these options were also outlined in the health professional questionnaire.
the oldest child in the family was three years (interquartile range: 1 to 6 years).
Health professional survey
Completed questionnaires were returned by 40/46 health professionals contacted, a response rate of 87%. Most respondents were paediatricians (50%, 20/40) or paediatric specialist nurses (38%, 15/40); five questionnaires were completed by other members of the clinic team (e.g. HIV physician).
Contact with general practitioners: parent survey
Almost all respondents (97%, 135/139) took their children to a general practitioner (GP) in addition to having HIV-related follow-up in the clinic. Disclosure of the family's HIV status to the GP was relatively common: 81% (109/135) reported that their GP knew about HIV in the family.
Long-term follow-up: both surveys
Nearly all parents (94%, 131/139) and all of the health professionals acknowledged that 'it is important to follow up uninfected children to see if there are any side effects from anti-HIV drugs'. A representative selection of respondents' comments from the questionnaires is provided in Table II .
Parents were asked to comment on four potential follow-up strategies (Table I) : 99% (139/140) indicated that at least one option was acceptable and 39% (55/140) more than one option. The majority (61%, 86/140) supported clinic contact, and only 4 (3%) strongly objected to it. Although only 24% (33/ 140) indicated that the no direct contact (data linkage) option was acceptable, only 11 (8%) strongly objected to it. Whether or not respondents approved particular options was not associated with available demographic or family characteristics, including age of their children. Most parents (77%, 105/136) did not strongly object to any of the options, but among those who did, postal contact was most unpopular (15/31) (Table III) .
All 40 health professional respondents considered at least one of the follow-up options acceptable: 70% (28/40) clinic contact, 58% (23/40) telephone contact, 55% (22/40) postal contact and 53% (21/40) the no direct contact (data linkage) option. Fifteen (38%) health professionals strongly objected to at least one option; 11 of these objected to clinic and/or telephone contact, most citing lack of clinic resources as their reason. Concerns about confidentiality and issues to do with the mobility of the families involved were also raised (see Table II ).
Future contact with the family: parent survey
Parents were asked what should happen if a potential health risk associated with exposure to a particular antiretroviral drug was identified: three respondents indicated that they would not want to be contacted under any circumstances, while 14% (19/140) felt that contact would only be appropriate if a treatment was available. The majority (84%, 118/ 140) however thought parents should be informed about any potential risk regardless of whether any treatment was available. Hypothetical ways by which parents might be approached were outlined in the Table II . Comments from questionnaires. Parent survey 'I think it is a good idea following up these children because it shows you have their interest at heart and would like to know and help them if they do get any side effects from the drugs.' [Mother of two children (aged 1 and 7 years)]
'When you are pregnant you are worried about the virus passing to baby and not strongly about the effects of the drugs.' [Mother of one child (aged 3 months)] 'Although I strongly support research into the follow-up of children exposed to anti HIV drugs I am currently unwilling to give my permission for this to happen as I feel that my decision of when or whether to tell my child about my HIV status could be taken out of my hands. If you can assure me this won't happen I will happily comply.' [Mother of one child (aged 1 year)] 'I think that GPs must be aware of any follow-up programme. I know some families with HIV are not always comfortable with this-but personally I find it crucial to keep our family health care as 'normal' as possible-less explaining, and I think less stigmatised.' [Mother of one child (aged 6 years)] 'I think that when they are still young it would be important to contact the carer. But once they're more mature then it's fine to contact them without the carer there.' [Mother of two children (aged 1 and 7 years)] 'I think it should be up to the parent to tell the clinic if they can contact the young person as it would necessitate the mother's disclosure of her own HIV status and this is a very personal, individual matter.'
[Mother of one child (aged 1 year)]
Health professional survey 'I think the concept of long-term follow-up needs to be raised when women are being either started on treatment or during pregnancy and then reiterated at all other visits for baby follow up i.e. birth, 6 weeks, 3 months and 18 months.' 'When parents are discharged they want to get away from us as fast as possible and start to live a 'normal' life.' 'There is a significant issue with respect to clinician and clinic time. As length of follow up proposed increases, number of contacts will grow. I deal with relatively low numbers but for a large patient load this is likely to become unmanageable.' 'Option C-I would be happy to ask families at last visit when uninfected but I do not think you will get good response as it is not something they can continue to feel 100% commitment to and that's what you need-other things become more important naturally over time.' 'Difficulties with keeping in touch with families, often move frequently.' questionnaire: a letter from the clinic, a telephone call, or a letter from researchers external to the clinic, but there was no consensus among respondents on which of these they preferred.
It was suggested that at some stage it would be more appropriate for the clinic or researchers to have direct contact with the young person themselves rather than with the parent, and respondents were asked their opinion about this. Eighteen of the 105 respondents (17%) who answered this question indicated that the young person should be contacted directly, 10 (10%) were not sure, but most (73%, 77/ 105) said it should be up to the parent to decide if and when the young person could be contacted. There was no association between parents' views about this and the age of their oldest child.
Discussion
Although almost everyone surveyed agreed that it was important to follow up uninfected children to identify possible side effects of ART exposure, contradictory views were expressed with respect to how contact should be maintained. Nevertheless, it was encouraging that few respondents strongly objected to specific potential follow-up strategies.
Clinic contact was preferred by both sets of respondents, but this is likely to reflect the fact that both are familiar with it, albeit for a relatively short period in the child's life. Some health professionals indicated that a lack of resources would make continuing clinic-based contact difficult for them to facilitate. In a comparable survey of parents/carers of hepatitis C infected children, most respondents also favoured long-term clinic-based follow-up, in preference to postal or telephone contact or data linkage (Personal communication, L Pembrey, 2006) .
Health professionals and parents mentioned anxieties about confidentiality as a reason why long-term follow-up was problematic, and some parents expressed concern that it could lead to inadvertent disclosure of maternal HIV status to the child. Fear of discrimination or isolation is likely to influence decisions about disclosure of HIV status to family and friends, as well as to health professionals (Anderson & Doyal, 2004) . Disclosure of parental HIV status to children has been shown to be associated with older age of the child, increased length of time since the parent's HIV diagnosis and severity of the parent's illness (Lee & Rotheram-Borus, 2002 , Vallerand et al., 2005 .
Most respondents to the parent survey thought they should be told about any potential health risk identified as associated with ART. Nevertheless, putting this into practice would be challenging, particularly since individuals expressed inconsistent preferences about the types of follow-up they found acceptable and how they would want to be contacted about any identified risk. Furthermore, if health risks were to be identified which could be screened for or treated, this would raise the question of whether disclosure of maternal HIV status and the young person's exposure status should occur regardless of parental consent.
Prophylactic ART to reduce the risk of MTCT was introduced in 1994 (Connor et al., 1994) and use of highly active ART (HAART) in pregnancy became widespread in the UK from 1998; consequently exposed children are still quite young. It is possible that parents might have different views on follow-up when their children are older. Other factors might be associated with adverse health outcomes among children growing up in families affected by HIV: some will have been exposed to Table III . Reasons for strong objections to follow-up options (31 parents).
Follow-up option(s)
Respondents with strong objections (n) Reason given (n) (1) Note : see Table I for a description of the follow-up options.
other infections and/or to non-ART drugs (prescribed or illicit) in fetal life; many will be affected by the death or illness of other family members, or other difficult family circumstances. If, during longterm follow-up, specific outcomes were recorded at a higher rate than in the general population, it would be necessary to undertake further work, such as case-control studies, to determine whether they were a direct result of exposure to ART. In the UK, there is an increasing prevalence of HIV in pregnancy coupled with high uptake of routine antenatal HIV testing. Prophylactic ART is recommended for all diagnosed HIV-infected pregnant women (Hawkins et al., 2005) and an increasing number of women are taking HAART for their own health when they conceive. Over 1000 uninfected infants were born to diagnosed women in the UK in 2005, and virtually all of them were exposed to ART in utero (NSHPC data); the annual number of exposed infants is likely to continue to increase. Despite the inherent difficulties, acceptable and practical forms of monitoring and follow-up must be developed to facilitate the identification of any substantial risk of serious adverse health effects in later life and to enable us to minimize any such risk, should it exist.
